Mike Ralston, CEO of Blencowe Resources, explains the significance of the MSP for Orom-Cross. Watch the interview here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksArrow Explor. Regulatory News (AXL)

Share Price Information for Arrow Explor. (AXL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.00
Bid: 27.50
Ask: 28.50
Change: 0.00 (0.00%)
Spread: 1.00 (3.636%)
Open: 28.00
High: 28.00
Low: 28.00
Prev. Close: 28.00

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Warrants and Operations Update

18 Oct 2023 15:21

RNS Number : 5706Q
Arrow Exploration Corp.
18 October 2023

The following amendments have been made to the announcement headed "Exercise of Warrants and Operations Update" released on 18 October 2023 at 07:00 under RNS No 4503Q.

In the paragraph headed "Tim Leslie Exercise" the following corrections have been made: Total holding is 17,012,245 Commons Shares and the corresponding percentage of current issued share capital of the Company is 6.0%.

All other details remain unchanged. The full amended text is shown below.

NOT FOR RELEASE, DISTRIBUTION, PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

ARROW ANNOUNCES EXERCISE OF WARRANTS BY LARGEST SHAREHOLDERS AND MANAGEMENT AND AN PROVIDES UPDATE ON RCE-6

CALGARY, October 18, 2023 - Arrow Exploration Corp. (AIM: AXL; TSXV: AXL) ("Arrow" or the "Company"), the high-growth operator with a portfolio of assets across key Colombian hydrocarbon basins, is pleased to announce the exercise of warrants in exchange for Common Shares in the Company ("Common Shares") by its largest shareholders and management. The warrants were issued in conjunction with the Q4 2021 financing and had an exercise price of GBP 0.09 per Common Share.

Canacol Exercise

The Company's largest shareholder, Canacol Energy Ltd. ("Canacol"), has exercised 18,357,602 warrants and is accordingly being issued the corresponding 1,8357,602 Common Shares. As a result of this exercise Canacol will hold a total of 60,072,807 Common Shares which represents 21.2% of the current issued share capital of the Company.

As per Canacol's press release dated October 16, 2023, Canacol intends to hold their current interest in the Company.

Tim Leslie Exercise

Another of the Company's largest shareholders, Tim Leslie, has exercised 10,204,082 warrants and is accordingly being issued the corresponding 10,204,082 Common Shares. As a result of this exercise, Tim Leslie will hold a total of 17,012,245 Common Shares which represents 6.0% of the current issued share capital of the Company.

Management Exercise

The Company's management have also exercised all warrants belonging to them as set out in the table below.

Management

Number of warrants exercised

Number of New Common Shares Issued

Aggregate number of Common Shares held following exercise

Total number of Common Shares held as a percentage of current issued share capital

Gage Jull

1,997,836

1,997,836

5,993,508

2.1%

Marshall Abbott

1,789,900

1,789,900

5,369,702

1.9%

Joe McFarlane

1,932,814

1,932,814

5,798,443

2.0%

At this time the Company's Management team plans to hold their current position in the Company.

Current Issued Share Capital

Following the issue of the new Common Shares described above, and pursuant to 3,600,000 Common Shares that have been issued under the Company's current blocklisting in the month of October to date, the issued share capital of the Company will be comprised by 283,408,275 Common Shares with one vote per share.

This figure of 283,408,275 has been used in the calculations above and may be used as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

The Company expects to have further warrants exercised at the end of the October under its Blocklisting and will therefore provide a revised Total Voting Rights figure at the end of the October once remaining warrants have either been exercised or expired.

Advance to Management

The Board of Directors have determined to provide loans to each of Messrs. Jull, Abbott and McFarlane (the "Executives"). The amount to be advanced to each Executive is $225,000 which will be repaid from future remuneration or other sources. The loans are due on demand, or when the Executive ceases to be employed by the Company, or when the Executive sells any Common Shares.

The Executives will execute loan agreements in respect of the advances and have agreed to provide security acceptable to the Company. The advances will bear interest at the Bank of Canada prime rate. Terms of the loans were reviewed and approved by the independent directors of the Company. Under Canadian Securities law the advances are subject to Multilateral Instrument 61-101 (Protection of Minority Security Holders in Special Transactions) but are exempt from the requirement for formal valuation or minority shareholder approval as the Company is not listed on a specified market as defined in the Instrument and the fair market value of the loans is less than 25% of the market capitalization of the Company.

Admission of Shares to trading on AIM

Save for the 28,561,684 new Common Shares to be issued to Canacol and Tim Leslie described above, all of the Common Shares issued and to be issued pursuant to the warrant exercises have already been admitted to trading on AIM pursuant to the Blocklisting as announced in the RNS dated 7 November 2022.

Accordingly, an additional application has been made for 28,561,684 new Common shares to be admitted to trading on AIM ("Admission"), with Admission expected to occur on or around 19 October 2023.

Operations Update

At the Rio Cravo Este (RCE) pad, the Company continues with the 2023 drilling program. The RCE-6 well spud on October 4th, and drilling operations are progressing as expected. Once the RCE-6 well is complete the company plans to drill two further wells at the RCE pad. Further updates will be issued once the well has been completed.

For further Information, contact:

Arrow Exploration

Marshall Abbott, CEO

+1 403 651 5995

Joe McFarlane, CFO

+1 403 818 1033

Brookline Public Relations, Inc.

Shauna MacDonald

+1 403 538 5645

Canaccord Genuity (Nominated Advisor and Joint Broker)

Henry Fitzgerald-O'Connor

James Asensio

Gordon Hamilton

+44 (0)20 7523 8000

Auctus Advisors (Joint Broker)

Jonathan Wright (Corporate)

+44 (0)7711 627449

Rupert Holdsworth Hunt (Broking)

Camarco (Financial PR)

Andrew Turner

+44 (0)20 3781 8331

Rebecca Waterworth

Kirsty Duff

About Arrow Exploration Corp.

Arrow Exploration Corp. (operating in Colombia via a branch of its 100% owned subsidiary Carrao Energy S.A.) is a publicly traded company with a portfolio of premier Colombian oil assets that are underexploited, under-explored and offer high potential growth. The Company's business plan is to expand oil production from some of Colombia's most active basins, including the Llanos, Middle Magdalena Valley (MMV) and Putumayo Basin. The asset base is predominantly operated with high working interests, and the Brent-linked light oil pricing exposure combines with low royalties to yield attractive potential operating margins. By way of a private commercial contract with the recognized interest holder before Ecopetrol S.A., Arrow is entitled to receive 50% of the production from the Tapir block. The formal assignment to the Company is subject to Ecopetrol's consent. Arrow's seasoned team is led by a hands-on executive team supported by an experienced board. Arrow is listed on the AIM market of the London Stock Exchange and on TSX Venture Exchange under the symbol "AXL".

Details of the person discharging managerial responsibilities / person closely associated

Name

1. Marshall Abbott

2. Gage Jull

3. Joe McFarlane

Reason for the notification

Position/status

1. Director

2. Director

3. PDMR (non-director)

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer

or auction monitor

Name

Arrow Exploration Corp.

LEI

9845000FDF0856QD9031

Details of the transaction(s): section to be repeated for (i) each type of instrument;

(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Identification code

Common Shares of nil par value

ISIN: CA04274P1053

Nature of the transaction

1. Exercise of warrants for common shares

2. Exercise of warrants for common shares

3. Exercise of warrants for common shares

Price(s) and volume(s)

Exercise

Name

Exercise price

Warrants

1. Marshall Abbott

GBP 0.09

1,789,900

2. Gage Jull

GBP 0.09

1,997,836

3. Joe McFarlane

GBP 0.09

1,932,814

Aggregated information

N/A

Date of the transaction

1. 16 October 2023

2. 16 October 2023

3. 16 October 2023

Place of the transaction

Outside a trading venue

Forward-looking Statements

This news release contains certain statements disclosures relating to Arrow that are based on the expectations of its management as well as assumptions made by and information currently available to Arrow which may constitute forward-looking statements information ("forward-looking statements") under applicable securities laws. All such statements and disclosures, other than those of historical fact, which address activities, events, outcomes, results developments that Arrow anticipates expects may, occur in the future (in whole in part) should be considered forward-looking statements. In some cases, forward-looking statements can be identified by the use of the words "continue", "expect", "opportunity", "plan", "potential" and "will" and similar expressions. The forward-looking statements contained in this news release reflect several material factors and expectations and assumptions of Arrow, including without limitation, Arrow's evaluation of the impacts of COVID-19, the potential of Arrow's Colombian and/Canadian assets (any of them individually), the prices of oil and/natural gas, and Arrow's business plan to expand oil and gas production and achieve attractive potential operating margins. Arrow believes the expectations and assumptions reflected in the forward-looking statements are reasonable at this time, but no assurance can be given that these factors, expectations, and assumptions will prove to be correct.

The forward-looking statements included in this news release are not guarantees of future performance and should not be unduly relied upon. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results events to differ materially from those anticipated in such forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company undertakes no obligations to update publicly revise any forward-looking statements, whether as a result of new information, future events otherwise, unless so required by applicable securities laws.

Neither TSX Venture Exchange nits Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility of the adequacy accuracy of this release.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCEALEPFAEDFFA
Date   Source Headline
27th Sep 20247:00 amRNSArrow Announces AGM Voting Results
23rd Sep 20247:00 amRNSFourth Ubaque Horizontal Well Results
12th Sep 20247:00 amRNSArrow Announces Grant of Stock Options
29th Aug 20247:00 amRNSThird Horizontal Well Results and Q2 2024 Results
21st Aug 20247:00 amRNSArrow Announces Filing of AGM Materials
14th Aug 20247:01 amRNSTR-1: Notification of major holdings
14th Aug 20247:00 amRNSTR-1: Notification of major holdings
31st Jul 20247:00 amRNSSecond Ubaque Horizontal Well Results
4th Jul 20247:00 amRNSPDMR Exercise of Options
21st Jun 20247:00 amRNSDirector/PDMR Shareholding
19th Jun 20247:00 amRNSFirst Ubaque Horizontal Well Results
4th Jun 20247:00 amRNSReplacement - Q1 2024 Interim Results
30th May 20247:00 amRNSQ1 2024 Interim Results
16th May 20247:00 amRNSArrow Announces the Spud of the CNB HZ-1 Well
8th May 20245:08 pmRNSTR-1: Notification of major holdings
30th Apr 20247:00 amRNSGrant of Stock Options
30th Apr 20247:00 amRNSTR-1: Notification of major holdings
29th Apr 20247:00 amRNS2023 Annual Results, MD&A and Reserves Report
2nd Apr 20245:10 pmRNSTR-1: Notification of major holdings
2nd Apr 20247:00 amRNSPDMR Exercise of Options
28th Mar 20247:00 amRNS2023 Year-End Reserves and Operations Update
20th Feb 20247:00 amRNSCN-4 and CN-5 Results
17th Jan 20247:00 amRNSOperations Update and PDMR Exercise of Options
4th Jan 20247:00 amRNSOperations Update and 2024 Guidance
29th Nov 20237:00 amRNSQ3 2023 Interim Results
16th Nov 20237:00 amRNSRCE-6 Update and Operations Update
7th Nov 20237:00 amRNSTR-1: Notification of major holdings
2nd Nov 20237:00 amRNSBlock Listing Update
26th Oct 20233:42 pmRNSTR-1: Notification of major holdings
25th Oct 20237:00 amRNSExercise of Warrants and TVR
20th Oct 202312:11 pmRNSTR-1: Notification of major holdings
19th Oct 20237:29 amRNSTR-1: Notification of major holdings
18th Oct 20233:21 pmRNSExercise of Warrants and Operations Update
18th Oct 20237:00 amRNSExercise of Warrants and Operations Update
29th Sep 20237:00 amRNSGrant Of Stock Options And TVR Update
21st Sep 20237:00 amRNSResult of AGM
18th Sep 20237:00 amRNSCN-3 Production and Production Update
11th Sep 20237:00 amRNSArrow Announces Maiden Carrizales Norte Reserves
7th Sep 20237:00 amRNSArrow Announces CN-3 Well Update
1st Sep 20237:00 amRNSTotal Voting Rights
29th Aug 20237:00 amRNSArrow Announces Q2 2023 Interim Results
21st Aug 20237:00 amRNSFiling of AGM Materials
1st Aug 20237:00 amRNSTotal Voting Rights
27th Jul 20237:05 amRNSIan Langley Appointed to Board of Directors
27th Jul 20237:00 amRNSCN-2 Well Results
25th Jul 20237:00 amRNSTR-1: Notification of major holdings
3rd Jul 20237:00 amRNSTotal Voting Rights Update
19th Jun 20237:00 amRNSCN-1 RESULTS AND OPERATIONS UPDATE
8th Jun 20237:00 amRNSCN-1 WELL UPDATE
1st Jun 20237:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Track Your Investments

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.